Last reviewed · How we verify
NCT03868683: GIF
The Glycemic Effect of Added Sugar on Bake Beans
NA trial testing Glucose Reference 1 in Diabetes Mellitus, Type 2 in 12 participants. Completed in 17 April 2019.
17 April 2019
Quick facts
| Lead sponsor | Singapore Institute of Food and Biotechnology Innovation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 20 August 2018 |
| Primary completion | 17 April 2019 |
| Estimated completion | 17 April 2019 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Glucose Reference 1
- Glucose Reference 2
- Glucose reference 3
- Sucrose — full drug profile →
- Regular Bake beans in tomato sauce
- Bake beans in tomato sauce, reduced sugar
- Bake beans in tomato sauce, low GI
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
- Obesity — all drugs for Obesity →
- PreDiabetes — all drugs for PreDiabetes →
Sponsor
Singapore Institute of Food and Biotechnology Innovation
Who can join
Adults 21 to 60, male only, with Diabetes Mellitus, Type 2 or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effect of added sugar to bake beans on glycemic and insulinemic response.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
High versus low-added sugar consumption for the primary prevention of cardiovascular disease.
Bergwall S, Johansson A, Sonestedt E, Acosta S. · · 2022 · cited 10× · PMID 34986271 · DOI 10.1002/14651858.cd013320.pub2
Verify or expand the search:
- PubMed search for NCT03868683
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Glucose Reference 1
Trials testing the same drug.
- NCT04228341 — The Effect of Degree of Rice-polishing on Glycaemic Response · NA · completed
- NCT03646812 — Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian Foods · NA · completed
- NCT03706378 — Food Modification to Alter Glycaemia and Insulinaemia · NA · completed
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Other Singapore Institute of Food and Biotechnology Innovation trials
Trials by the same sponsor.
- NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
- NCT06691126 — Pharmacokinetic Study of Terpinolene in Healthy Subjects (PKT Study) · NA · completed
- NCT06421194 — Functional and Nutritional Plant-based Mixed Protein Study (FuN Protein Study) · NA · recruiting
- NCT06119035 — Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor · NA · completed
- NCT06640335 — The Effects of Vegetable Preloading on Postprandial Glycemia, Insulinaemia and Gastric Emptying · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03868683 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Singapore Institute of Food and Biotechnology Innovation
- Last refreshed: 17 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03868683.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing